Find out how to get
Free shipping

Moment - ibuprofen 200 mg - 10 soft capsuless

4.9
(57)
See all products: Moment
Productor: Angelini
info prodotto Richiedi info sul prodotto
-38.08%
€5.51
Recommended price €8.90
Available in the following sizes
  • 10 soft capsules
    €5.51
  • 12 coated tablets
    €4.89
  • 24 coated tablets
    Not available
  • 36 coated tablets
    €10.37
Extra quantity discount
from 5 Pieces You're saving: 1,00%
from 10 Pieces You're saving: 2,00%
info resi e spedizione

Information on returns and shipments

info pagamenti

Payment methods

Authorized company for online trading of
Medicines authorized by the Ministry of Health
99& satisfied customers
Product Description

Therapeutic indications

Moment is used to treat pain of various origins and natures (headache, toothache, neuralgia, osteoarticular and muscular pain, menstrual pain). It is an adjuvant in the symptomatic treatment of fever and flu.

Dosage and method of use

Moment is administered according to the following doses: Adults and adolescents over 12 years: 1-2 capsules, 2-3 times a day. Do not exceed the dose of 6 capsules per day. If use of the medicine is necessary for more than 3 days in adolescents, or in case of worsening symptoms, a doctor should be consulted. Do not exceed the recommended doses; elderly patients in particular should stick to the minimum doses indicated above. Take the product on a full stomach.

Moment capsules contain:

Active ingredient:

- Ibuprofen 200 mg

Excipients (Macrogol 600, potassium hydroxide, gelatin, partially dehydrated liquid sorbitol, purified water, Ponceau 4R (E124), lecithin, fractionated coconut oil)

Sorbitol: patients with rare hereditary problems of fructose intolerance should not take this medicine; Ponceau 4R (E124): may cause allergic reactions. cause allergic reactions.

Pregnancy and breastfeeding

Hypersensitivity to the active substance, to other antirheumatics (acetylsalicylic acid, etc.) or to any of the excipients. Active or severe gastroduodenal ulcer or other gastropathies. History of gastrointestinal bleeding or perforation related to previous active treatments or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding). Severe hepatic or renal insufficiency. Severe cardiac insufficiency.

Inhibition of prostaglandin synthesis may adversely affect pregnancy and/or embryo/fetal development. Results of epidemiological studies suggest an increased risk of miscarriage and cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk of cardiac malformations increased from less than 1% to approximately 1.5%. The risk was believed to increase with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to result in increased pre- and post-implantation loss and embryo-fetal mortality. Furthermore, an increased incidence of various malformations, including cardiovascular, has been reported in animals administered prostaglandin synthesis inhibitors during the organogenetic period. During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to: cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension); renal dysfunction, which may progress to renal failure with oligohydramnios; and the mother and newborn. At the end of pregnancy, to: possible prolongation of bleeding time and an antiplatelet effect that may occur even at very low doses; Inhibition of uterine contractions resulting in delayed or prolonged labor.

Special warnings

Do not administer to children under 12 years of age.

Use caution in patients whose activity requires vigilance if they notice drowsiness, dizziness, or depression during therapy with ibuprofen. The use of the drug, as with any drug inhibiting the synthesis of prostaglandins and cyclooxygenase, is not recommended in women attempting to conceive. Administration should be suspended in women who have fertility problems or who are undergoing investigation of fertility. The use of the medicine should be avoided in conjunction with NSAIDs, including selective COX-2 inhibitors. Undesirable effects can be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms. Clinical studies and epidemiological data suggest that the use of ibuprofen, particularly at high doses (2400 mg/day) and for long-term treatment, may be associated with a modest increased risk of arterial thrombotic events (e.g. myocardial infarction or stroke).

Storage

Store below 25°C.

Format

Moment 200 mg in pack of 10 Soft Capsules

Product Code:FRCM058473

Price Trend

This product has been on sale since 25/09/2017

In the last 30 days, the product's lowest price was 5,32 €

5% EXTRA DISCOUNT on FIRST ORDER! Register and discover the WELCOME Coupon!
To enhance your website experience, Farmacosmo.com uses different types of cookies. You can click OK, to allow them, or manage them individually. By clicking on the ''x'' you don't accept any cookies and other tracking methods other than technical ones. To read more see our Cookie Policy. Cookie Policy